Vikas Gupta

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (11)

Srdan Verstovsek

UNITED STATES

View details

Sergio Giralt

Chief Attending, Adult BMT Service

Memorial Sloan Kettering Cancer Center

UNITED STATES

View details

Juan Carlos Hernandez-Boluda

University of Valencia

SPAIN

View details

Donal P. McLornan

UNITED KINGDOM

View details

Muhammad Bilal Abid

UNITED STATES

View details

Jean-Jacques Kiladjian

FRANCE

View details

Dawn Maze

Assistant Professor

University of Toronto

CANADA

View details

Aaron Gerds

Assitant Professor

Cleveland Clinic

UNITED STATES

View details

Bruno Leonel Ferreyro

Assistant Professor

University of Toronto

CANADA

View details

PRITHVIRAJ BOSE

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Adam Smith

Assistant Professor

University of Toronto

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Vikas Gupta

Research Interests

Explore related searches

Contact this professor

Articles (11)

Biallelic disruption of DDX41 activity is associated with distinct genomic and immunophenotypic hallmarks in acute leukemia

Comparison of clinical outcomes between transplant and nontransplant therapies in myelofibrosis following failure of first-line JAK-inhibitor

Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis

A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis

Matching-adjusted indirect comparison of the pelabresib-ruxolitinib combination vs JAKi monotherapy in myelofibrosis

Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib.

Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration.

Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis.

Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trials.

Exclusion of persistent mutations in splicing factor genes and isocitrate dehydrogenase 2 improves the prognostic power of molecular measurable residual disease assessment in acute myeloid leukemia.

Symptom Trajectory in Hematopoietic Stem Cell Transplantation Recipients Who Survive Critical Illness

Collaborators (11)

Srdan Verstovsek

Sergio Giralt

Juan Carlos Hernandez-Boluda

Donal P. McLornan

Muhammad Bilal Abid

Jean-Jacques Kiladjian

Dawn Maze

Aaron Gerds

Bruno Leonel Ferreyro

PRITHVIRAJ BOSE

Adam Smith

Make your next move.